Compound class:
Synthetic organic
Comment: This compound binds to PPARγ without any agonist activity [1]. It inhibits CDK5-mediated phosphorylation of PPARγ at Ser273. Compound 10 was designed for antidiabetic potential, as an alternative to thiazolidinedione class antihyperglycemic PPARγ agonist drugs such as rosiglitazone and pioglitazone.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Inhibits phosphorylation of PPARγ Ser273 with IC50 of 160 nM [1]. |
Selectivity at nuclear hormone receptors | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|